BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27102854)

  • 1. Economic Approaches to Estimating Benefits of Regulations Affecting Addictive Goods.
    Cutler DM; Jessup AI; Kenkel DS; Starr MA
    Am J Prev Med; 2016 May; 50(5 Suppl 1):S20-S26. PubMed ID: 27102854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.
    Weimer DL; Vining AR; Thomas RK
    Health Econ; 2009 Feb; 18(2):181-202. PubMed ID: 18566968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic man and the consumption of addictive goods: the case of two goods.
    Andersson L; Bask M; Melkersson M
    Subst Use Misuse; 2006; 41(4):453-66. PubMed ID: 16522558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis.
    Verguet S; Gauvreau CL; Mishra S; MacLennan M; Murphy SM; Brouwer ED; Nugent RA; Zhao K; Jha P; Jamison DT
    Lancet Glob Health; 2015 Apr; 3(4):e206-16. PubMed ID: 25772692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking kills: An economic theory of addiction, health deficit accumulation, and longevity.
    Strulik H
    J Health Econ; 2018 Nov; 62():1-12. PubMed ID: 30261429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling a two-tier tobacco excise tax policy to reduce smoking by focusing on the addictive component (nicotine) more than the tobacco weight.
    Laugesen M
    N Z Med J; 2012 Dec; 125(1367):35-48. PubMed ID: 23321882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment costs, withdrawal effects, and cigarette addiction.
    Jones AM
    J Health Econ; 1999 Jan; 18(1):125-37. PubMed ID: 10338818
    [No Abstract]   [Full Text] [Related]  

  • 8. Does smuggling negate the impact of a tobacco tax increase?
    Tsui TC
    Tob Control; 2016 May; 25(3):361-2. PubMed ID: 26085122
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demand analysis of tobacco consumption in Malaysia.
    Ross H; Al-Sadat NA
    Nicotine Tob Res; 2007 Nov; 9(11):1163-9. PubMed ID: 17978990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame.
    Cobiac LJ; Ikeda T; Nghiem N; Blakely T; Wilson N
    Tob Control; 2015 Jun; 24(e2):e154-60. PubMed ID: 25145342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual cigarette consumption and addiction: a flexible limited dependent variable approach.
    Yen ST; Jones AM
    Health Econ; 1996; 5(2):105-17. PubMed ID: 8733103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation.
    Igarashi A; Goto R; Suwa K; Yoshikawa R; Ward AJ; Moller J
    Appl Health Econ Health Policy; 2016 Feb; 14(1):77-87. PubMed ID: 26597111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do consumers of manufactured cigarettes respond differently to price changes compared with their Roll-Your-Own counterparts? Evidence from New Zealand.
    Tait P; Rutherford P; Saunders C
    Tob Control; 2015 May; 24(3):285-9. PubMed ID: 24259046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental influences on tobacco use: evidence from societal and community influences on tobacco use and dependence.
    Cummings KM; Fong GT; Borland R
    Annu Rev Clin Psychol; 2009; 5():433-58. PubMed ID: 19327036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Price and trade: World No Tobacco Day 2015.
    Rimmer M
    Tob Control; 2015 Jun; 24(e2):e123-4. PubMed ID: 26025095
    [No Abstract]   [Full Text] [Related]  

  • 19. Addiction surplus: the add-on margin that makes addictive consumptions difficult to contain.
    Adams PJ; Livingstone C
    Int J Drug Policy; 2015 Jan; 26(1):107-11. PubMed ID: 25175598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recent and projected public health and economic benefits of cigarette taxation in Greece.
    Alpert HR; Vardavas CI; Chaloupka FJ; Vozikis A; Athanasakis K; Kyriopoulos I; Bertic M; Behrakis PK; Connolly GN
    Tob Control; 2014 Sep; 23(5):452-4. PubMed ID: 23467654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.